Ansel P Nalin

9PUBLICATIONS
36CO-AUTHORS
Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 07, 2026
Control arm overperformance in phase 3 oncology clinical trials.

Ansel P Nalin, Pavlos Msaouel, Adam J Grippin

|Sep 23, 2022
Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors.

Jennifer K Matsui, Haley K Perlow, Rohit K Raj

|Mar 05, 2022
Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma.

Bethany L Mundy-Bosse, Christoph Weigel, Yue-Zhong Wu

|Aug 21, 2021
Acute Myeloid Leukemia Alters Group 1 Innate Lymphoid Cell Differentiation from a Common Precursor.

Matthew R Lordo, Kevin G Wu, Ekaterina Altynova

|Nov 07, 2020
Stage I Squamous Cell Carcinoma of the Anus: Is Radiation Therapy Alone Sufficient Treatment?

Eric Miller, Ansel Nalin, Dayssy Diaz Pardo

|Oct 06, 2020
Notch Regulates Innate Lymphoid Cell Plasticity during Human NK Cell Development.

Ansel P Nalin, Jesse J Kowalski, Alexander C Sprague

Pageof 2